Press Releases

Mercy Medical Center is advancing orthopedic care in the Mid-Atlantic region with the introduction of Mako SmartRobotics™ technology for shoulder replacement surgery. The technology, which enhances precision and personalization in shoulder arthroplasty procedures, is now available to patients through orthopedic shoulder specialist Gregory V. Gasbarro, M.D., among the first in the Mid-Atlantic region performing robotic Mako shoulder arthroplasty. The addition of Mako SmartRobot

Kardium Inc., a medical device solutions company behind the Globe® System, announced the launch of the “Globe Durability Guarantee”™, which is designed to provide patients and physicians with additional confidence in the Globe System’s ability to deliver durable treatment with only one procedure. The Globe Durability Guarantee promises that if a patient treated with the Globe System returns for a redo ablation and pulmonary vein reconnection is observed,

Emboline, Inc., a medical technology company developing next-generation embolic protection technology, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Emboliner® Embolic Protection System for use during transcatheter heart procedures. The Emboliner is indicated for use as an embolic protection device to capture and remove embolic material during transcatheter aortic valve replacement (TAVR). The Emboliner system is designed t

GE HealthCare today announced that StarGuide GX,i its new digital 4D CZT SPECT/CT technology, is 510(k) pending with the U.S. Food and Drug Administration (FDA). Building on the system’s recent CE Mark, this milestone is a step towards expanding access to advanced molecular imaging technologies in the United States and marks a significant moment in molecular imaging’s evolution – aiming to empower clinicians with a high-performance, general purpose scanner to help personaliz

Carestream Healthcare International is introducing the latest version of its DRX‑LC Detector, delivering enhanced imaging performance, efficiency, and quality for long‑length imaging across a wide range of exams and clinical environments. Long‑length imaging has traditionally been time‑consuming and complex, often requiring multiple exposures and image stitching. Carestream's DRX‑LC Detector simplifies this process with single‑shot long‑length imaging, enabling rad

West Physics Consulting, LLC ("West Physics"), the leading national provider of integrated medical and health physics consulting services, announced today that it has acquired Radiographic Testing Services ("RTS"), an Albany, NY medical physics provider of Nuclear Medicine, Diagnostic Radiology, Radiation Oncology and Certified Radiation Equipment Safety Officer (CRESO) services. The acquisition brings together two organizations with complementary capabilities an

Medibyt, a digital health company focused on transforming cardiopulmonary diagnostics through intelligent automation, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to CPETWise (K260242). The clearance marks a major milestone for Medibyt and enables the company to enter the U.S. commercialization phase. CPETWise is designed to streamline CPET analysis, interpretation, and reporting by transforming complex physiological data in

GE HealthCare (Nasdaq: GEHC) recently achieved CE Mark for Photonova Spectra,i an advanced photon-counting computed tomography (PCCT) system with the company’s proprietary Deep Silicon™ detector technology. The regulatory milestone expands access and enables clinical adoption of the technology in CE Mark–observing countries and underscores GE HealthCare’s commitment to purposeful, customer-driven innovation in computed tomography (CT). “We are proud to

Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today unveiled new Waystar AltitudeAI-powered agentic capabilities that autonomously take action across critical revenue cycle workflows, advancing the company's vision for an autonomous revenue cycle. Built on Waystar's end-to-end platform, payer connectivity, and proprietary data spanning more than 7.5 billion transactions and approximately 60% of U.S. patients, these innovations advance Waystar'

IceCure Medical Ltd. developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced that it has entered into an exclusive distribution agreement (the "Agreement") with Scovas Medical ("Scovas") for the distribution of IceCure's ProSense® cryoablation systems in the Netherlands for breast cancer and interventional oncology. Under the Agreement, Scovas will serve as IceCure